Prp19/CDC5L promotes gastric cancer via activation of the MAPK pathway-mediated homologous recombination
International Journal of Biological Sciences · 2025
DOI: 10.7150/ijbs.101962 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Shengkui Qiu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, Nantong 226001, Jiangsu Province, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Cell Cycle Proteins, MAP Kinase Signaling System, Homologous Recombination. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Recent advances in gastric cancer (GC) treatment have not substantially improved the 5-year survival rate nor have they significantly reduced the high recurrence rate. This highlights the need for further research to explore the underlying mechanisms of GC. Cell Division Cycle 5-Like Protein (CDC5L) has been implicated in various malignant behaviors of tumors.
Methods
We investigated the expression of CDC5L in gastric cancer (GC) using data from The Cancer Genome Atlas (TCGA) and clinical specimens. To explore the role of CDC5L in GC, we conducted in vitro and in vivo assays, alongside molecular mechanism studies using luciferase reporter assays, co-immunoprecipitation (CO-IP), and mass spectrometry (MS).
Results
Our findings indicate a significant elevation of CDC5L in GC, with CDC5L overexpression correlating with poorer survival outcomes, advanced TNM stages, and higher pathological grades in GC patients. In vitro, interference of CDC5L markedly inhibited GC progression. We discovered that the Pre-mRNA Processing Factor 19 (Prp19) directly binds to the CDC5L promoter, enhancing its transcription and inhibiting its lysosome-mediated degradation. Additionally, CO-IP and MS assays revealed that CDC5L interacts with MAPK1, activating the MAPK signaling axis and consequently augmenting homologous recombination in GC.
Conclusions
In summary, our study confirms that Prp19 upregulates CDC5L expression, which binds to MAPK1, thereby promoting GC progression via the MAPK pathway-mediated homologous recombination. Targeting CDC5L could be a promising strategy in the precision therapy of GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, Nantong 226001, Jiangsu Province, China.
- Department of General Surgery, Affiliated Hospital of Nantong University, Nantong 226000, Jiangsu Province, China.
- Department of Gastroenterology, Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, Nantong 226001, Jiangsu Province, China.
- Nantong Clinical Medical College, Kangda College of Nanjing Medical University, Nantong 226001, Jiangsu Province, China.
Zitieren
APA
Qiu, S., Wang, F., Gao, X., Guan, W., Dai, T., Yin, L., Wang, F., Sun, J., Guo, P., Wu, H., Feng, S., & Tang, C. (2025). Prp19/CDC5L promotes gastric cancer via activation of the MAPK pathway-mediated homologous recombination. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.101962
Vancouver
Qiu S, Wang F, Gao X, Guan W, Dai T, Yin L, et al. Prp19/CDC5L promotes gastric cancer via activation of the MAPK pathway-mediated homologous recombination. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.101962
BibTeX
@article{Qiu2025,
author = {Qiu, Shengkui and Wang, Feiran and Gao, Xuesong and Guan, Weiyu and Dai, Ting and Yin, Lei and Wang, Fei and Sun, Jinjie and Guo, Peng and Wu, Hao and Feng, Shichun and Tang, Chong},
title = {Prp19/CDC5L promotes gastric cancer via activation of the MAPK pathway-mediated homologous recombination},
journal = {International Journal of Biological Sciences},
year = {2025},
doi = {10.7150/ijbs.101962}
}
EUVIMED